Identification of heterogeneous ribonucleoprotein A1 as a novel substrate for protein kinase C zeta.

TitleIdentification of heterogeneous ribonucleoprotein A1 as a novel substrate for protein kinase C zeta.
Publication TypeJournal Article
Year of Publication1995
AuthorsMunicio MM, Lozano J, Sanchez P, Moscat J, Diaz-Meco MT
JournalJ Biol Chem
Volume270
Issue26
Pagination15884-91
Date Published1995 Jun 30
ISSN0021-9258
KeywordsAnimals, Base Sequence, Cyclic AMP-Dependent Protein Kinases, HeLa Cells, Humans, Molecular Sequence Data, Peptide Mapping, Phosphorylation, Protein Kinase C, Rats, Recombinant Proteins, Ribonucleoproteins, RNA
Abstract

The zeta isoform of protein kinase C (zeta PKC) has been shown to be an important step in mitogenic signal transduction. Using a yeast interaction screen to search for potential novel substrates of zeta PKC, we identified the heterogeneous ribonucleoprotein A1 (hnRNPA1). This protein specifically interacts with the catalytic domain of zeta PKC but not with its regulatory region or with the full-length protein, or with a kinase-defective mutant of the zeta PKC catalytic domain. In addition, no interaction was detected with other kinases such as Raf-1 or Mos, that, like zeta PKC, are critically involved in signal transduction, or with the catalytic domain of epsilon PKC, which is the PKC isotype with the highest homology to zeta PKC. hnRNPA1 is directly phosphorylated by both recombinant and native zeta PKC, and this phosphorylation is increased when zeta PKC is immunoprecipitated from mitogen-activated fibroblasts. As an additional control, hnRNPA1 is not phosphorylated appreciably by catalytic epsilon PKC or by a mixture of highly purified classical PKC isotypes maximally activated by phosphatidylserine and Ca2+. Treatment of quiescent cell cultures with a potent mitogen such as platelet-derived growth factor promotes a significant phosphorylation of hnRNPA1 in vivo that is impaired by expression of a dominant negative mutant of zeta PKC. Furthermore, expression of a catalytically active zeta PKC mutant phosphorylates hnRNPA1 in vivo. These findings suggest that zeta PKC could be critically involved in a novel pathway that connects membrane signaling to nuclear regulatory events, at the level of RNA transport and processing. Results also shown here by using different zeta PKC mutants suggesting the control of the cytoplasmic localization of hnRNPA1 by zeta PKC. Also of potential functional relevance are the results demonstrating that the phosphorylation by zeta PKC severely impairs both hnRNPA1 RNA binding and its ability to promote strand annealing in vitro.

DOI10.1074/jbc.270.26.15884
Alternate JournalJ Biol Chem
PubMed ID7541049
Related Faculty: 
Jorge Moscat, Ph.D. Maria Diaz-Meco Conde, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700